Anti-inflammatory activity of Lactobacillus spp. and Rhodopseudomonas palustris probiotics
DOI:
https://doi.org/10.31989/bchd.v6i4.1067Abstract
Background: Probiotics have been used for many years to promote human health by mitigating inflammation. However, their mechanisms have not been fully elucidated. During inflammation, excessive and/or prolonged production of pro-inflammatory cytokines is related with various inflammatory diseases and cancer. Several probiotics have been reported as playing a role in suppressing the level of pro-inflammatory cytokines, as the human body attempts to recover itself. The aim of this study was to evaluate the anti-inflammatory activity of probiotics consisting of Lactobacillus spp. and Rhodopseudomonas palustris on macrophage RAW 264.7 cells.
Methods: The probiotics mixture was centrifuged to separate supernatant, i.e., the probiotics extract, from the cells. The probiotics extract was then evaluated for its effects on cell viability and for anti-inflammatory activity of LPS inflammation-induced RAW 264.7 cells.
Results: The results showed that the probiotics extract was able to decrease the level of IFN-γ, IL-1β, TNF-α, IL-8, TGF-β1 pro-inflammatory cytokines or mRNAs, and increase the level of IL-10 anti-inflammatory mRNA.
Conclusion: The probiotics extract was identified to have anti-inflammatory activity. Thus, the probiotics are promising to be used for treatment of chronic inflammatory conditions.
Keywords: multi-strain probiotics, anti-inflammatory cytokine/mRNA, RAW264.7
Downloads
Published
Issue
Section
License
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.